Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 October, 2017 23:50 IST
Sun Pharma receives EIR from USFDA for Dadra facility
Source: IRIS | 12 Oct, 2017, 10.23AM
Comments  |  Post Comment

Sun Pharmaceutical Industries has received an Establishment Inspection Report (EIR) from the US Food Drug and Administration (USFDA) in respect of Dadra facility based upon the company’s responses to the observation letter.

EIR is issued to the entity when the USFDA concludes that an inspection is closed under Title 21 Section 20.64 (d) (3) of Code of Federal Regulation.

Total volume of shares traded on the bourses today was lower by 42.34% to 3,573,833 compared with 22-day average volume of 6,197,935.

Shares of the company gained Rs 9.55, or 1.82%, to trade at Rs 535.35. The total volume of shares traded was 193,487 at the BSE (10.07 a.m., Thursday).



Sun Pharmaceutical Industries Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Suven Life Sciences secures product patent in Singapore - 18-Oct-2017 10:42
Wipro quarterly profit climbs 6% - 18-Oct-2017 10:24
Bajaj Auto Q2 earnings fall marginally to Rs 11.93 bn - 17-Oct-2017 15:43
ACC Q3 profit soars 2.02 times to Rs 1.81 bn - 17-Oct-2017 15:15
Goodricke Group enters inks pact with Godfrey Phillips India - 17-Oct-2017 15:08
Nihar Info Global inks pact with Ibibo group - 17-Oct-2017 12:33
Aurobindo Pharma gets nod for Esomeprazole capsules - 17-Oct-2017 11:38
SSWL bags export order of caravan wheels from Europe - 17-Oct-2017 11:35
Jain Irrigation's pipe division bags order of Rs 1.78 bn - 16-Oct-2017 11:34
Bharti Airtel, Millicom conclude deal to combine ops in Ghana - 16-Oct-2017 10:21
IRB Infra's SPV achieves financial closure for NH-79 BOT project - 16-Oct-2017 10:05
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer